Immersive VR hypnosis to reduce anxiety in nurses
Use of Immersive Virtual Reality for the Management of Anxiety Among Nurses : a Randomized Trial
NA · SCP Anesthésie - Réanimation de la Clinique du Pont de Chaume · NCT07293221
This pilot will try short hypnotic immersive VR sessions to see if they reduce anxiety in day-shift nurses during their coffee break.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 56 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | SCP Anesthésie - Réanimation de la Clinique du Pont de Chaume (other) |
| Locations | 1 site (Montauban) |
| Trial ID | NCT07293221 on ClinicalTrials.gov |
What this trial studies
This open-label, randomized pilot trial at a single center will randomize day-shift nurses to receive a short hypnotic immersive VR session during their scheduled 9:00–9:15 coffee break or to usual rest. Anxiety will be measured immediately before and after the break using standardized scales and the analysis will follow an intention-to-treat approach. Secondary outcomes include nurse satisfaction with the break experience. The protocol excludes night-shift nurses and those with contraindications to immersive VR such as photosensitive epilepsy or severe vestibular disorders.
Who should consider this trial
Good fit: Ideal candidates are day-shift nurses at the Montauban clinic who have a scheduled 9:00 coffee break, consent to participate, and have no contraindications to immersive VR.
Not a fit: Nurses with photosensitive epilepsy, unstable vestibular disorders, severe motion sickness, those on night shifts, or those unable to participate during work hours are unlikely to benefit from this intervention.
Why it matters
Potential benefit: If successful, this could provide a quick, non-drug way for nurses to lower anxiety and improve rest and job satisfaction during their shift.
How similar studies have performed: Immersive VR and hypnotic VR interventions have shown anxiety-reducing effects in other patient groups in prior randomized studies, but evidence specifically in nursing staff is limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Nurses who have received appropriate information, agreed to participate, and signed the informed consent form. Nurses working day shifts (06:00-18:00) with a coffee break scheduled from 09:00 to 09:15. Exclusion Criteria: Nurses who have not provided informed consent or cannot comply with the study protocol. History of photosensitive epilepsy or seizures. Unstable vestibular disorders or a severe history of motion sickness preventing the use of immersive VR. Employer refusal if participation cannot be organized outside work obligations (participation must remain voluntary and without professional consequences).
Where this trial is running
Montauban
- Clinique du Pont de Chaume - Montauban — Montauban, France (RECRUITING)
Study contacts
- Principal investigator: Edmundo P PEREIRA DE SOUZA NETO, Phd — Clinique du Pont de Chaume - Montauban
- Study coordinator: Edmundo P PEREIRA DE SOUZA NETO, PhD
- Email: edmundo.pereira-de-souza@hotmail.fr
- Phone: 0770017259
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Anxiety, Nurse Based Care Management